Nature Biotechnology, Published online: 06 June 2023; doi:10.1038/s41587-023-01818-4The GLP-1 agonist Wegovy has re-energized the hunt for obesity treatments. Alternatives — ranging from bitter taste compounds to lean muscle boosters and bacteria — are already in the clinic…
Read More
About The Author
